JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

PerkinElmer Inc

Fechado

SetorSaúde

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

-8.6M

47M

Vendas

-21M

699M

P/E

Médio do Setor

50.083

37.003

EPS

0.4

Rendimento de Dividendos

0.28

Margem de lucro

6.675

Funcionários

11,000

EBITDA

-14M

181M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+15.19% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.28%

2.25%

Próxima data de dividendos

7 de nov. de 2025

Próxima data de ex-dividendo

16 de jan. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

584M

11B

Abertura anterior

0

Fecho anterior

0

Sentimento de Notícias

By Acuity

31%

69%

98 / 373 Ranking em Healthcare

PerkinElmer Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de out. de 2025, 23:28 UTC

Ações em Alta

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

29 de out. de 2025, 23:07 UTC

Ganhos

Prudential PLC 3Q New Business Profit Up 13%

30 de out. de 2025, 00:00 UTC

Ganhos

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

30 de out. de 2025, 00:00 UTC

Ganhos

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

30 de out. de 2025, 00:00 UTC

Ganhos

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

29 de out. de 2025, 23:46 UTC

Conversa de Mercado

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

29 de out. de 2025, 23:40 UTC

Ganhos

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

29 de out. de 2025, 23:38 UTC

Conversa de Mercado

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

29 de out. de 2025, 23:25 UTC

Ganhos

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

29 de out. de 2025, 22:51 UTC

Ganhos

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

29 de out. de 2025, 22:45 UTC

Ganhos

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

29 de out. de 2025, 22:41 UTC

Ganhos

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

29 de out. de 2025, 22:41 UTC

Ganhos

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

29 de out. de 2025, 22:09 UTC

Ganhos

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

29 de out. de 2025, 22:08 UTC

Conversa de Mercado
Ganhos

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

29 de out. de 2025, 21:58 UTC

Ganhos

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

29 de out. de 2025, 21:58 UTC

Ganhos

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

29 de out. de 2025, 21:57 UTC

Ganhos

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

29 de out. de 2025, 21:54 UTC

Ganhos

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

29 de out. de 2025, 21:46 UTC

Ganhos

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

29 de out. de 2025, 21:43 UTC

Ganhos

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

29 de out. de 2025, 21:43 UTC

Ganhos

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

29 de out. de 2025, 21:42 UTC

Ganhos

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

29 de out. de 2025, 21:42 UTC

Ganhos

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

29 de out. de 2025, 21:41 UTC

Ganhos

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

29 de out. de 2025, 21:41 UTC

Ganhos

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

29 de out. de 2025, 21:41 UTC

Ganhos

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

29 de out. de 2025, 21:41 UTC

Ganhos

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

29 de out. de 2025, 21:40 UTC

Ganhos

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

29 de out. de 2025, 21:39 UTC

Ganhos

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Comparação entre Pares

Variação de preço

PerkinElmer Inc Previsão

Preço-alvo

By TipRanks

15.19% parte superior

Previsão para 12 meses

Média 111.1 USD  15.19%

Máximo 125 USD

Mínimo 100 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para PerkinElmer Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

11 ratings

8

Comprar

3

Manter

0

Vender

Sentimento

By Acuity

98 / 373 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat